BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, March 14, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 26, 2021
View Archived Issues
NKMAX studies SNK-01 with chemotherapy and cetuximab in advanced NSCLC
Read More
New phase II trial evaluates BDB-001 for PD-(L)1 refractory solid tumors
Read More
Progress in the search for opioid multitarget ligands for persistent pain relief
Read More
ECM1a isoform plays a tumorigenic role and confers cancer cell cisplatin resistance
Read More
Deep intronic F9 gene variants linked to hemophilia B
Read More
Enteric HDL shown to prevent liver injury via portal vein
Read More
Targeting TYMP as potential new therapeutic strategy against COVID-19
Read More
Sunshine Lake Pharma, Dongguan Hec New Drug Research and Development patent RORgammaT antagonists
Read More
Multiple kinase inhibitors identified at Medshine Discovery
Read More
New glucagon-like peptide 1 derivatives identified at Gan & Lee Pharmaceuticals
Read More
Heterodimeric interference among IKZF family proteins results in inborn errors of immunity
Read More
Denali reports interim data from phase I/II study of DNL-310 in Hunter's syndrome
Read More
Shionogi initiates phase I trial in Japan of 3CL protease inhibitor S-217622 for COVID-19
Read More
Innovent initiates phase Ia study of anti-PD-1/TIGIT bispecific antibody IBI-321
Read More
DSMB reviews phase Ib part of ILIAD study of ilixadencel with pembrolizumab in advanced cancers
Read More
New mouse model created for cerebral venous sinus thrombosis
Read More
Cortexyme selects 3CLpro inhibitor COR-803 to treat coronavirus infections
Read More
FDA clears IND for phase I study of NT-I7 for Kaposi sarcoma
Read More
MediWound's MW-005 studied in clinical trials for BCC and nonmelanoma skin cancers
Read More
Aurion releases preliminary findings from study of cell therapy for corneal endothelial disease
Read More
